SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem
- Conditions
- COVID19
- Interventions
- Diagnostic Test: Breath sample
- Registration Number
- NCT04497610
- Lead Sponsor
- Instituto Costarricense de Investigaciones Clínicas ICIC
- Brief Summary
The purpose of the study is to verify the sensibility and accuracy of a rapid detection test for SARS-CoV-2 in breath samples analyzed by the breath detector analyzer TeraSystem, comparing with PCR tests.
- Detailed Description
BioSafety Technologies has developed a rapid detection test to clear people of COVID-19.
A person can undergo an easy non-invasive test, to determine if they are: COVID-19 Clear (Negative) or Infected (Positive). The user-friendly process does not involve medically trained personnel.
The study will compare TeraSystem test results against PCR test results. Persons participating will be persons having a PCR test as part of the Health System and consenting to participate.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Older than 7 years odf age Able to provide informed consent Able to take the breath test
Younger than 7 years of age Unable to provide informed consent Unable to take the breath test
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Positive TeraSystem test Breath sample Patients having positive PCR tests will undergo TeraSystem test Negative TeraSystem test Breath sample Patients having negative PCR tests will undergo TeraSystem test
- Primary Outcome Measures
Name Time Method Presence of disease 1 minute Established diagnosis
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Instituto Costarricense de Investigaciones Clínicas
🇨🇷San José, Costa Rica